FDA approves magnetic device system for guiding sentinel lymph node biopsies in certain patients with breast cancer

July 24, 2018 – The U.S. Food and Drug Administration today approved a magnetic device system for guiding lymph node biopsies in patients with breast cancer undergoing mastectomy. The Magtrace and Sentimag Magnetic Localization System (Sentimag System) uses magnetic detection during sentinel lymph node biopsy procedures to identify specific lymph nodes, known as sentinel lymph nodes, for surgical removal. “Sentinel lymph node biopsies are crucial for … (leggi tutto)